Vision Response to Dopamine Replacement

Stopped early · Phase 2

Conditions studied: Albinism, Oculocutaneous Albinism

In brief

The purpose of the study is to evaluate and document physiologic and functional changes in visual performance and retinal function of patients diagnosed with albinism (a dopamine deficiency state) following a trial of oral Levodopa/carbidopa treatment.

Key facts

Study ID

NCT01663935

Run by

University of Wisconsin, Madison

People needed

20

Starts

2012-10-17

Expected to finish

2018-04-12

Last updated by the study team

2019-06-11

Who can join

Age: 3 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• clinical diagnosis of oculocutaneous albinism
• age over 3 and weight over 25 lbs.

You may not qualify if…

• ocular only albinism
• ocular pathology other than albinism
• neurologic disease, history of myocardial infarction, history of clinical depression, pregnancy

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.